Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase.
Amino Acid Motifs
Amino Acid Sequence
Animals
Antigens, Neoplasm
/ chemistry
Axin Protein
Fibroblasts
/ metabolism
HEK293 Cells
Humans
Male
Mice, Knockout
Models, Biological
Organ Specificity
Poly ADP Ribosylation
Prostate
/ metabolism
Protein Domains
Proteolysis
Stromal Cells
/ metabolism
Substrate Specificity
Tankyrases
/ antagonists & inhibitors
Ubiquitination
Wnt Signaling Pathway
Zebrafish
Axin
PAGE4
PARylation
RNF146
TNKS
Tankyrase
Wnt
cancer-testis antigen
prostate
β-catenin
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
21 07 2020
21 07 2020
Historique:
received:
10
03
2020
revised:
30
04
2020
accepted:
26
06
2020
entrez:
23
7
2020
pubmed:
23
7
2020
medline:
29
4
2021
Statut:
ppublish
Résumé
Spatiotemporal control of Wnt/β-catenin signaling is critical for organism development and homeostasis. The poly-(ADP)-ribose polymerase Tankyrase (TNKS1) promotes Wnt/β-catenin signaling through PARylation-mediated degradation of AXIN1, a component of the β-catenin destruction complex. Although Wnt/β-catenin is a niche-restricted signaling program, tissue-specific factors that regulate TNKS1 are not known. Here, we report prostate-associated gene 4 (PAGE4) as a tissue-specific TNKS1 inhibitor that robustly represses canonical Wnt/β-catenin signaling in human cells, zebrafish, and mice. Structural and biochemical studies reveal that PAGE4 acts as an optimal substrate decoy that potently hijacks substrate binding sites on TNKS1 to prevent AXIN1 PARylation and degradation. Consistently, transgenic expression of PAGE4 in mice phenocopies TNKS1 knockout. Physiologically, PAGE4 is selectively expressed in stromal prostate fibroblasts and functions to establish a proper Wnt/β-catenin signaling niche through suppression of autocrine signaling. Our findings reveal a non-canonical mechanism for TNKS1 inhibition that functions to establish tissue-specific control of the Wnt/β-catenin pathway.
Identifiants
pubmed: 32698014
pii: S2211-1247(20)30903-7
doi: 10.1016/j.celrep.2020.107922
pii:
doi:
Substances chimiques
AXIN1 protein, human
0
Antigens, Neoplasm
0
Axin Protein
0
PAGE4 protein, human
0
Tankyrases
EC 2.4.2.30
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
107922Subventions
Organisme : CIHR
ID : PJT374609
Pays : Canada
Organisme : NIGMS NIH HHS
ID : P30 GM124165
Pays : United States
Organisme : NIH HHS
ID : S10 OD021527
Pays : United States
Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests P.R.P. is a paid consultant for Levo Therapeutics, Inc., and Amgen, Inc.